NAUTILUS BIOTECHNOLOGY INC (NAUT)
US63909J1088 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 1.00M | |||
| Cash Equivalents | 25.73M | 19.40M | 114.50M | 185.60M | 36.60M | |||
| Marketable Securities | 155.64M | 154.02M | 69.90M | 160.10M | 40.10M | |||
| Other Current Assets | 3.73M | 3.42M | 2.70M | 3.50M | 900.00K | |||
| Total Current Assets | 185.09M | 176.84M | 187.20M | 349.20M | 77.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 36.08M | 36.90M | 32.60M | 31.90M | 6.20M | |||
| Investments And Advances | 66.29M | 90.65M | 129.20M | 16.40M | 149.55M | |||
| Other Non-Current Assets | 1.18M | 1.18M | 1.10M | 1.00M | 1.10M | |||
| Total Non-Current Assets | 103.56M | 128.73M | 162.90M | 49.30M | 7.30M | |||
| TOTAL ASSETS | 288.65M | 305.56M | 350.10M | 398.50M | 85.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.35M | 7.48M | 5.50M | 4.10M | 2.50M | |||
| Accounts Payable | 1.86M | 1.64M | 1.30M | 1.70M | 500.00K | |||
| Total Current Liabilities | 9.21M | 9.12M | 6.80M | 5.80M | 3.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 29.95M | 31.09M | 28.30M | 29.10M | 3.30M | |||
| Total Non-Current Liabilities | 29.95M | 31.09M | 28.30M | 29.10M | 3.30M | |||
| TOTAL LIABILITIES | 39.16M | 40.21M | 35.10M | 34.90M | 6.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -220.97M | -202.24M | -138.60M | -80.60M | -30.30M | |||
| Additional Paid In Capital | 471.19M | 467.83M | 455.30M | 444.40M | 600.00K | |||
| Common Shares | 13.00K | 13.00K | 0.00 | 0.00 | 108.40M | |||
| Other Shareholders' Equity | -745.00K | -255.00K | -1.90M | -200.00K | 0.00 | |||
| Shares Outstanding | 125.27M | 125.07M | 124.90M | 124.30M | 124.10M | |||
| Tangible Book Value per Share | 1.99 | 2.12 | 2.52 | 2.93 | -0.24 | |||
| Total Shareholders' Equity | 249.49M | 265.35M | 314.90M | 363.60M | 78.70M | |||
| TOTAL LIABILITIES AND EQUITY | 288.65M | 305.56M | 350.10M | 398.50M | 85.00M | |||
| Statistics | ||||||||
| Current Ratio | 20.09 | 19.39 | 27.53 | 60.21 | 25.90 | |||
| Return On Assets (ROA) | -23.37% | -20.84% | -16.54% | -12.63% | -18.38% | |||
| Return On Equity (ROE) | -27.03% | -24.00% | -18.39% | -13.84% | -19.85% | |||
All data in USD